Cargando…
Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 65 years and is particularly associated with phenotypic heterogeneity. Atypical presentations, such as the clinic-radiological visual syndrome posterior cortical atrophy (PCA), often lead to delays in accurate diagn...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545969/ https://www.ncbi.nlm.nih.gov/pubmed/28824534 http://dx.doi.org/10.3389/fneur.2017.00377 |
_version_ | 1783255515262877696 |
---|---|
author | Pavisic, Ivanna M. Firth, Nicholas C. Parsons, Samuel Rego, David Martinez Shakespeare, Timothy J. Yong, Keir X. X. Slattery, Catherine F. Paterson, Ross W. Foulkes, Alexander J. M. Macpherson, Kirsty Carton, Amelia M. Alexander, Daniel C. Shawe-Taylor, John Fox, Nick C. Schott, Jonathan M. Crutch, Sebastian J. Primativo, Silvia |
author_facet | Pavisic, Ivanna M. Firth, Nicholas C. Parsons, Samuel Rego, David Martinez Shakespeare, Timothy J. Yong, Keir X. X. Slattery, Catherine F. Paterson, Ross W. Foulkes, Alexander J. M. Macpherson, Kirsty Carton, Amelia M. Alexander, Daniel C. Shawe-Taylor, John Fox, Nick C. Schott, Jonathan M. Crutch, Sebastian J. Primativo, Silvia |
author_sort | Pavisic, Ivanna M. |
collection | PubMed |
description | Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 65 years and is particularly associated with phenotypic heterogeneity. Atypical presentations, such as the clinic-radiological visual syndrome posterior cortical atrophy (PCA), often lead to delays in accurate diagnosis. Eyetracking has been used to demonstrate basic oculomotor impairments in individuals with dementia. In the present study, we aim to explore the relationship between eyetracking metrics and standard tests of visual cognition in individuals with YOAD. Fifty-seven participants were included: 36 individuals with YOAD (n = 26 typical AD; n = 10 PCA) and 21 age-matched healthy controls. Participants completed three eyetracking experiments: fixation, pro-saccade, and smooth pursuit tasks. Summary metrics were used as outcome measures and their predictive value explored looking at correlations with visuoperceptual and visuospatial metrics. Significant correlations between eyetracking metrics and standard visual cognitive estimates are reported. A machine-learning approach using a classification method based on the smooth pursuit raw eyetracking data discriminates with approximately 95% accuracy patients and controls in cross-validation tests. Results suggest that the eyetracking paradigms of a relatively simple and specific nature provide measures not only reflecting basic oculomotor characteristics but also predicting higher order visuospatial and visuoperceptual impairments. Eyetracking measures can represent extremely useful markers during the diagnostic phase and may be exploited as potential outcome measures for clinical trials. |
format | Online Article Text |
id | pubmed-5545969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55459692017-08-18 Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions Pavisic, Ivanna M. Firth, Nicholas C. Parsons, Samuel Rego, David Martinez Shakespeare, Timothy J. Yong, Keir X. X. Slattery, Catherine F. Paterson, Ross W. Foulkes, Alexander J. M. Macpherson, Kirsty Carton, Amelia M. Alexander, Daniel C. Shawe-Taylor, John Fox, Nick C. Schott, Jonathan M. Crutch, Sebastian J. Primativo, Silvia Front Neurol Neuroscience Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 65 years and is particularly associated with phenotypic heterogeneity. Atypical presentations, such as the clinic-radiological visual syndrome posterior cortical atrophy (PCA), often lead to delays in accurate diagnosis. Eyetracking has been used to demonstrate basic oculomotor impairments in individuals with dementia. In the present study, we aim to explore the relationship between eyetracking metrics and standard tests of visual cognition in individuals with YOAD. Fifty-seven participants were included: 36 individuals with YOAD (n = 26 typical AD; n = 10 PCA) and 21 age-matched healthy controls. Participants completed three eyetracking experiments: fixation, pro-saccade, and smooth pursuit tasks. Summary metrics were used as outcome measures and their predictive value explored looking at correlations with visuoperceptual and visuospatial metrics. Significant correlations between eyetracking metrics and standard visual cognitive estimates are reported. A machine-learning approach using a classification method based on the smooth pursuit raw eyetracking data discriminates with approximately 95% accuracy patients and controls in cross-validation tests. Results suggest that the eyetracking paradigms of a relatively simple and specific nature provide measures not only reflecting basic oculomotor characteristics but also predicting higher order visuospatial and visuoperceptual impairments. Eyetracking measures can represent extremely useful markers during the diagnostic phase and may be exploited as potential outcome measures for clinical trials. Frontiers Media S.A. 2017-08-07 /pmc/articles/PMC5545969/ /pubmed/28824534 http://dx.doi.org/10.3389/fneur.2017.00377 Text en Copyright © 2017 Pavisic, Firth, Parsons, Rego, Shakespeare, Yong, Slattery, Paterson, Foulkes, Macpherson, Carton, Alexander, Shawe-Taylor, Fox, Schott, Crutch and Primativo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Pavisic, Ivanna M. Firth, Nicholas C. Parsons, Samuel Rego, David Martinez Shakespeare, Timothy J. Yong, Keir X. X. Slattery, Catherine F. Paterson, Ross W. Foulkes, Alexander J. M. Macpherson, Kirsty Carton, Amelia M. Alexander, Daniel C. Shawe-Taylor, John Fox, Nick C. Schott, Jonathan M. Crutch, Sebastian J. Primativo, Silvia Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions |
title | Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions |
title_full | Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions |
title_fullStr | Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions |
title_full_unstemmed | Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions |
title_short | Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions |
title_sort | eyetracking metrics in young onset alzheimer’s disease: a window into cognitive visual functions |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545969/ https://www.ncbi.nlm.nih.gov/pubmed/28824534 http://dx.doi.org/10.3389/fneur.2017.00377 |
work_keys_str_mv | AT pavisicivannam eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT firthnicholasc eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT parsonssamuel eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT regodavidmartinez eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT shakespearetimothyj eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT yongkeirxx eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT slatterycatherinef eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT patersonrossw eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT foulkesalexanderjm eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT macphersonkirsty eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT cartonameliam eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT alexanderdanielc eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT shawetaylorjohn eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT foxnickc eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT schottjonathanm eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT crutchsebastianj eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions AT primativosilvia eyetrackingmetricsinyoungonsetalzheimersdiseaseawindowintocognitivevisualfunctions |